CA2455444A1 - Methods and devices for heart valve treatments - Google Patents
Methods and devices for heart valve treatments Download PDFInfo
- Publication number
- CA2455444A1 CA2455444A1 CA002455444A CA2455444A CA2455444A1 CA 2455444 A1 CA2455444 A1 CA 2455444A1 CA 002455444 A CA002455444 A CA 002455444A CA 2455444 A CA2455444 A CA 2455444A CA 2455444 A1 CA2455444 A1 CA 2455444A1
- Authority
- CA
- Canada
- Prior art keywords
- medical device
- framework
- leaflet
- heart
- wire
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/50—Supports for surgical instruments, e.g. articulated arms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22097—Valve removal in veins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320052—Guides for cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/904—Heart
Abstract
Published without an
Description
METHODS AND DEVICES FOR HEART VALVE TREATMENTS
REFERENCE TO PENDING PRIOR PATENT APPLICATION
This patent application claims benefit of pending prior U.S. Provisional Patent Application Serial Number 60/326,590 filed October l, 2001 by John A.
Macoviak, which patent is hereby incorporated by reference.
FIELD OF THE INVENTION
This invention relates to methods and devices to improve the function of heart valves.
More particularly, the invention relates to methods and devices to treat mural valve regurgitation.
BACKGROUND OF THE INVENTION
The opening and closing of heart valves occur primarily as a result of pressure differences. For example, the opening and closing of the mitral valve occurs as a result of the pressure differences between the left atrium and the left ventricle. During ventricular diastole, when ventricles are relaxed, the venous return of blood from the pulmonary veins into the left atrium causes the pressure in the atrium to exceed that in the ventricle. As a result, the mural valve opens, allowing blood to enter the ventricle. As the ventricle contracts during ventricular systole, the intraventricular pressure rises above the pressure in the atrium and pushes the mitral valve shut.
The high pressure produced by contraction of the ventricle could push the valve leaflets too much and even them. Prolapse is a term used to describe this condition.
This is normally prevented by contraction of the papillary muscles within the ventricle, which are connected to the mural valve leaflets by the chordae tendineae (chords). Contraction of the papillary muscles is simultaneous with the contraction of the ventricle and serves to keep healthy valve leaflets tightly shut at peak contraction pressures exerted by the ventricle.
Valve malfunction can result from the chords becoming stretched, and in some cases tearing. When a chord tears, the result is a flailed leaflet. Also, a normally structured valve may not function properly because of an enlargement of the valve annulus. This condition is referred to as a dilation of the annulus and generally results from heart muscle failure. In addition, the valve may be defective at birth or because of an acquired disease.
SUMMARY OF THE INVENTION
The present invention is a group of medical devices designed to improve heart valve function. The medical devices may be used individually, or in combination to supplement damaged valves, replace damaged valves, or improve damaged valves function.
The medical devices include leaflet retainers, a neo-annulus, neo-leaflet, and a framework. In addition, the present invention includes novel methods for surgically treating heart valves.
BRIEF DESCRIPTION OF THE DRAWINS
Figure 1 shows a posterior oblique cutaway view of a patient's heart 100.
Figure 2 shows a cutaway view of a patient's heart 200 with a prolapsed mitral valve that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction.
Figure 3 shows a cutaway view of a patient's heart 300 with a flailing mural valve 320 that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction as indicated by arrows.
Figure 4 shows a perspective view of a spring bridge neo-leaflet used to supplement or replace a native leaflet.
Figure 5 shows a perspective view of an embodiment of the invention comprised of a bridge 540, spanning material 530, attachment means 550, and a base 520. In addition, the device is shown to have a framework 510.
Figure 6 shows a perspective view of the embodiment of Figure 5 in the open valve position.
Figure 7 shows a perspective view of the embodiments shown in Figures 5 and 6 positioned within the left atrium of the heart.
Figures 8 and 9 show a perspective view of the embodiments of Figures S and 6 positioned within the left atrium of the heart.
REFERENCE TO PENDING PRIOR PATENT APPLICATION
This patent application claims benefit of pending prior U.S. Provisional Patent Application Serial Number 60/326,590 filed October l, 2001 by John A.
Macoviak, which patent is hereby incorporated by reference.
FIELD OF THE INVENTION
This invention relates to methods and devices to improve the function of heart valves.
More particularly, the invention relates to methods and devices to treat mural valve regurgitation.
BACKGROUND OF THE INVENTION
The opening and closing of heart valves occur primarily as a result of pressure differences. For example, the opening and closing of the mitral valve occurs as a result of the pressure differences between the left atrium and the left ventricle. During ventricular diastole, when ventricles are relaxed, the venous return of blood from the pulmonary veins into the left atrium causes the pressure in the atrium to exceed that in the ventricle. As a result, the mural valve opens, allowing blood to enter the ventricle. As the ventricle contracts during ventricular systole, the intraventricular pressure rises above the pressure in the atrium and pushes the mitral valve shut.
The high pressure produced by contraction of the ventricle could push the valve leaflets too much and even them. Prolapse is a term used to describe this condition.
This is normally prevented by contraction of the papillary muscles within the ventricle, which are connected to the mural valve leaflets by the chordae tendineae (chords). Contraction of the papillary muscles is simultaneous with the contraction of the ventricle and serves to keep healthy valve leaflets tightly shut at peak contraction pressures exerted by the ventricle.
Valve malfunction can result from the chords becoming stretched, and in some cases tearing. When a chord tears, the result is a flailed leaflet. Also, a normally structured valve may not function properly because of an enlargement of the valve annulus. This condition is referred to as a dilation of the annulus and generally results from heart muscle failure. In addition, the valve may be defective at birth or because of an acquired disease.
SUMMARY OF THE INVENTION
The present invention is a group of medical devices designed to improve heart valve function. The medical devices may be used individually, or in combination to supplement damaged valves, replace damaged valves, or improve damaged valves function.
The medical devices include leaflet retainers, a neo-annulus, neo-leaflet, and a framework. In addition, the present invention includes novel methods for surgically treating heart valves.
BRIEF DESCRIPTION OF THE DRAWINS
Figure 1 shows a posterior oblique cutaway view of a patient's heart 100.
Figure 2 shows a cutaway view of a patient's heart 200 with a prolapsed mitral valve that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction.
Figure 3 shows a cutaway view of a patient's heart 300 with a flailing mural valve 320 that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction as indicated by arrows.
Figure 4 shows a perspective view of a spring bridge neo-leaflet used to supplement or replace a native leaflet.
Figure 5 shows a perspective view of an embodiment of the invention comprised of a bridge 540, spanning material 530, attachment means 550, and a base 520. In addition, the device is shown to have a framework 510.
Figure 6 shows a perspective view of the embodiment of Figure 5 in the open valve position.
Figure 7 shows a perspective view of the embodiments shown in Figures 5 and 6 positioned within the left atrium of the heart.
Figures 8 and 9 show a perspective view of the embodiments of Figures S and 6 positioned within the left atrium of the heart.
2 Figure 10 shows a perspective view of an embodiment of the invention having a framework 1010 that avoids the pulmonary veins (not shown).
Figures 11 and 12 show a perspective view of a dual spring bridge neo-leaflet having an anterior bridge spanned by an anterior material 1110, and a posterior bridge spanned by a posterior material 1120.
Figure 13 shows a perspective view of a damaged native anterior leaflet 1310 that is not connected to the chordae tendineae.
Figure 14 shows a perspective view of a device 1400 having a half sewing ring 1420 with a membrane 1410 that serves as a neo-annulus or a neo-leaflet.
Figure 15 shows a perspective view of a device 1500 having a full sewing ring 1530 with a membrane 1510 that serves as a neo-annulus or a neo-leaflet.
Figure 16 shows a perspective view of a leaflet retainer 1600 that is positioned within the atrium on top of both native mural valve leaflets.
" Figure 17 shows a perspective view of a leaflet retainer 1700 that is positioned within the atrium on top of both native mural valve leaflets.
Figure 18 shows a perspective view of a leaflet retainer 1800~that is positioned within the atrium on top of both native mitral valve leaflets.
Figure 19 shows a perspective view of a leaflet retainer 1900 that is positioned on top of both native mitral valve leaflets.
Figure 20 shows a side view of the embodiment shown in Figure 19.
Figure 21 shows a perspective view of the embodiment shown in Figure 19.
Figure 22 through 26 show the sequence of steps for a catheter-based percutaneous deployment of an embodiment of the invention.
Figure 27 shows a perspective view of an embodiment of the invention 2700 having a framework that partially fills the atrium.
Figure 28 shows a perspective view of an embodiment of the invention 2800 having dual neo-leaflets, 2830 and 2840.
Figure 29 shows a perspective view of an embodiment of the invention 2900 having a leaflet retainer 2910 positioned against a native leaflet as well as a framework structure 2920 that meanders about the atrium without interfering with the pulmonary veins.
Figure 30 shows a perspective view of another embodiment of the invention 3000 consisting of a continuous wire or tube that forms a leaflet retainer and framework.
Figure 31 shows a perspective view of a tulip shaped wire form configuration 3100 of the invention.
Figure 32 shows cutaway view of a tulip shaped wire form configuration 3200 of the invention.
Figure 33 shows a cutaway view of a tulip with a twist wire form configuration 3300 of the invention.
Figure 34 shows a cutaway view of the left atrium and left ventricle. The arrows on the left side of the figure indicate by way of example three different ways in which an embodiment of the invention, such as a leaflet retainer, neo-leaflet, or neo-annulus, may interact with the mitral valve, or be positioned if replacing a leaflet.
Figure 35 shows a perspective view of mesh leaflet with buttressing 3500.
Figure 36 shows a side view of a corona configuration 3600 of the invention.
Figure 37 shows a perspective view of a corona configuration 3700 of the invention in situ within a patient's left atrium.
Figure 38 shows a cutaway view of a heart, having both native leaflets, 3810 and 3820, intact.
Figure 39 shows a cutaway view of a heart with one embodiment of the invention 3900.
Figure 40 shows a cutaway view of a heart with one intact mitral valve leaflet 4010, and one mural valve leaflet excised, or missing.
Figure 41 shows a cutaway view of a heart with one embodiment of the invention 4100.
In addition, the shown embodiment has one neo-leaflet 4110.
Figure 42 shows a cutaway view of a heart with both mural valve leaflets removed.
Figure 43 shows a cutaway view of a heart with one embodiment of the invention having two neo-leaflets.
DETAILED DESCRIPTION
Figure 1 shows a posterior oblique cutaway view of a patient's heart 100. Two of the four heart chambers are shown, the left atrium 170, and the left ventricle 140 (not shown are the right atrium and right ventricle). The left atrium 170 fills with blood from the pulmonary veins.
The blood then passes through the mitral valve (also known as the bicuspid valve, and more generally known as an atrioventricular valve) during ventricular diastole and into the left ventricle 140. During ventricular systole, the blood is then ejected out of the left ventricle 140 through the aortic valve 150 and into the aorta 160. At this time, the mitral valve should be shut so that blood is not regurgitated back into the left atrium. The mitral valve consists of two leaflets, an anterior leaflet 110, and a posterior leaflet 115, attached to chordae tendineae 120 (hereafter, chords), which in turn are connected to papillary muscles 130 within the left atrium 140. Typically, the mitral valve has a D-shaped anterior leaflet 110 oriented toward the aortic valve, with a crescent shaped posterior leaflet 115. The leaflets intersect with the atrium 170 at the mitral annulus 190.
Figure 2 shows a cutaway view of a patient's heart 200 with a prolapsed mural valve that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction. The anterior 220 and posterior 225 leaflets are shown being blown into the left atrium with arrows indicating the direction of regurgitant flow. Among other causes, regurgitation can result from stretched chords 210 that are too long to prevent the leaflets from being blown into the atrium. As a result, the leaflets do not form a tight seal and blood is regurgitated into the atrium.
Figure 3 shows a cutaway view of a patient's heart 300 with a flailing mitral valve 320 that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction as indicated by arrows. Among other causes, regurgitation can result from torn chords 310.
Figure 4 shows a perspective view of a spring bridge neo-leaflet used to supplement or replace a native leaflet. The device 400 is shown to be formed of a base 420 that is positioned around the mitral annulus, and then closes in over the anterior leaflet to form a bridge 430 over the anterior leaflet. The bridge 430 may be a rigid, semi-rigid, or flexible.
The bridge may act like a spring, and thus respond dynamically to pressure differentials within the heart. The bridge 430 may have a spanning material 410 that spans the bridge 430. The spanning material 410 may be attached to the device 400 with one or more attachment means 440 (for example, it may be sewn, glued, or welded to the device 400, or it may be attached to itself when wrapped around the device 400). The spanning material 410 may be made from a synthetic material (for example, thin Nitinol, Dacron fabric, Polytetrafluoroethylene or PTFE, Silicone, or Polyurethane) or a biological material (for example, human or animal pericardium). The device 400 may be delivered percutaneously, through the chest (thoracoscopy), or using open heart surgical techniques. If delivered percutaneously, the device may be made from a super-elastic material (for example, Nitinol) enabling it to be folded and collapsed such that it can be delivered in a catheter, and will subsequently self expand when released from the catheter. The device may be secured to the mural annulus with sutures or other attachment means (i.e. barbs, hooks, staples, etc).
Figure S shows a perspective view of an embodiment of the invention comprised of a bridge 540, spanning material 530, attachment means SSO, and a base 520. In addition, the device is shown to have a framework S 10. Preferably the framework S 10 does not interfere with atrial contractions, instead contracting with the atrium. As such, the device 500 may have non-uniform flexibility to improve its function within the heart. The framework is shown here rising from the base 520 with two substantially parallel arched wires that connect to form a semicircular hoop above the base 520. The framework 510 helps to accurately position the device within the atrium, and also helps to secure the device within the atrium. The neo-leaflet comprised of the bridge 540 and spanning material 530 is shown in the closed valve position.
Figure 6 shows a perspective view of the embodiment of Figure 5 in the open valve position.
Figure 7 shows a perspective view of the embodiments shown in Figures 5 and 6 positioned within the left atrium of the heart.
Figures 8 and 9 show a perspective view of the embodiments of Figures S and 6 positioned within the left atrium of the heart. Figure 8 shows the embodiment in a closed valve position, and Figure 9 shows the embodiment in an open valve position. The sizing of the base 810 can vary depending upon the patient's needs.
Figure 10 shows a perspective view of an embodiment of the invention having a framework 1010 that avoids the pulmonary veins (not shown).
Figures 11 and 12 show a perspective view of a dual spring bridge neo-leaflet have an anterior bridge spanned by an anterior material 1110, and a posterior bridge spanned by a posterior material 1120. The framework 1130 shown here illustrates an alternative design. This embodiment also illustrates a base having clips 1140 that protrude below an imaginary plane formed by the annulus of the valve. Figure 11 shows the dual neo-leaflets in a closed valve position, and Figure 12 shows the dual neo-leaflets in an open valve position.
Figure 13 shows a perspective view of a damaged native anterior leaflet 1310 that is not connected to the chordae tendineae.
Figure 14 shows a perspective view of a device 1400 having a half sewing ring 1420 with a membrane 1410 that serves as a neo-annulus or a neo-leaflet. When serving as a neo-annulus, the membrane 1410 is a relatively immobile structure covering one of the native valve leaflets, particularly a damaged, missing or nonfunctional leaflet. The neo-annulus serves to extend the native annulus and coapts with the remaining functional native leaflet to create a functioning mitral valve. When serving as a neo-leaflet, the membrane 1410 is a mobile structure that moves in response to blood flow, coapting with one of the native leaflets to create a functioning mural valve. The neo-leaflet replaces the function of a damaged, missing or nonfunctional native leaflet. The device 1400 is attached to the mural valve annulus via the half sewing ring 1420.
This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 15 shows a perspective view of a device 1500 having a full sewing ring 1530 with a membrane 1510 that serves as a neo-annulus or a neo-leaflet. The device 1500 has an opening 1520 though the sewing ring 1530 opposite the membrane 1510 for blood flow.
Alternatively, this embodiment could have two neo-leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 16 shows a perspective view of a leaflet retainer 1600 that is positioned within the atrium on top of both native mural valve leaflets. This embodiment is comprised of an outer ring 1610 and an inner ring 1630 connected by radial struts 1620. The interior region of the valve orifice remains unobstructed to blood flow with this embodiment. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 17 shows a perspective view of a leaflet retainer 1700 that is positioned within the atrium on top of both native mural valve leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 18 shows a perspective view of a leaflet retainer 1800 that is positioned within the atrium on top of both native mitral valve leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 19 shows a perspective view of a leaflet retainer 1900 that is positioned on top of both native mural valve leaflets. Alternatively, the leaflet retainers may be designed to retain only one leaflet, or a portion of a leaflet, depending on patient needs. The outer sections of this embodiment have anchors 1910 that distribute stresses along the atrial wall, helping to prevent erosion of the atrial walls. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 20 shows a side view of the embodiment shown in Figure 19.
Figure 21 shows a perspective view of the embodiment shown in Figure 19.
Figure 22 through 26 show the sequence of steps for a catheter-based percutaneous deployment of an embodiment of the invention. This deployment technique applies to other embodiments as well. Initially, a guidewire is introduced into the vasculature via a peripheral venous access site, such as the femoral or jugular vein, or alternatively by means of surgical access through the right atrium. Figure 22 shows the introduction of a guidewire 2210 through the septum 2220 between the right and left atria. The guidewire is shown being introduced into the right atrium via the inferior vena cava 2230. Figure 23 shows a catheter 2320 being advanced over the guidewire 2310. Figure 24 shows an embodiment of the invention 2400 being released from the catheter after the guidewire has been removed.
Alternatively, a guidewire could be used to place the device. Figure 25 shows an embodiment of the invention having an additional feature, a looped eyelet 2500 that is being placed within a pulmonary vein to help position the device within the atrial chamber. The looped eyelet 2500 could be advanced over a guidewire. Figure 26 shows an embodiment of the invention 2600 being positioned within the left atrium. The device 2600 can be positioned or repositioned within the atrium using a catheter deployed grasping instrument 2610.
Figure 27 shows a perspective view of an embodiment of the invention 2700 having a framework that partially fills the atrium.
Figure 28 shows a perspective view of an embodiment of the invention 2800 having dual neo-leaflets, 2830 and 2840. The device is comprised of a framework 2810 an annular base 2820, and the neo-leaflets, 2830 and 2840. The neo-leaflets supplement or replace native leaflets, and thus function as a one-way valve to allow blood to flow from the atrium to the ventricle, and to prevent blood from flowing from the ventricle to the atrium.
This is accomplished because the neo-leaflets structure is similar to native leaflet structure.
Figure 29 shows a perspective view of an embodiment of the invention 2900 having a leaflet retainer 2910 positioned against a native leaflet as well as a framework structure 2920 that meanders about the atrium without interfering with the pulmonary veins. The leaflet retainer 2910 prevents the leaflet from prolapsing into the atrium due to the pressure differential during ventricular contractions, thus improving closure of the mitral valve and reducing regurgitation.
Figure 30 shows a perspective view of another embodiment of the invention 3000 consisting of a continuous wire or tube that forms a leaflet retainer and framework. The geometry of the framework is such that it spirals upward within the atrium.
The device 3000 is secured in place because the framework expands within the atrium, and experiences mural pressures. The leaflet retainer is secured in place over 'a native leaflet by its coupling to the framework, and the leaflet retainer functions to prevent the native leaflet from experiencing prolapse. In addition, a coating that promotes tissue growth may aid in the fixation process of the framework within the atrium. However, the leaflet retainer section of the device 3000 may benefit from a coating that inhibits tissue growth, thus allowing the native leaflet to allow blood to flow into the ventricle.
Figure 31 shows a perspective view of a tulip shaped wire form configuration 3100 of the invention.
Figure 32 shows cutaway view of a tulip shaped wire form configuration 3200 of the invention. The illustration shows the device 3200 making contact with native leaflets, 3220 and 1 S 3210, to prevent prolapse. The device 3200 is comprised of a leaflet retainer section that functions to prevent the native leaflets, 3210 and 3220, from being blown into the atrium when the ventricle contracts. The leaflet retaining section is positioned directly over the native leaflets.
In this embodiment, the leaflet retaining aspect of the device 3200 is shown to be integrally formed with the framework section of the device. However, in other embodiments, the leaflet retainer and framework may be separate structures which can be deployed separately for individual use or in combination.
Figure 33 shows a cutaway view of a tulip with a twist wire form configuration 3300 of the invention. The twist aspect enables the device to be shortened through twisting to decrease the longitudinal spring constant. The device 3300 is comprised of a leaflet retainer section that functions to prevent the native leaflets from being blown into the atrium when the ventricle contracts. The leaflet retaining section is positioned directly over the native leaflets. In this embodiment, the leaflet retaining aspect of the device 3300 is shown to be integrally formed with the framework section of the device. However, in other embodiments, the leaflet retainer and framework may be separate structures which can be deployed separately for individual use or in combination.
Figure 34 shows a cutaway view of the left atrium and left ventricle. The arrows on the left side of the figure indicate by way of example three different ways in which an embodiment of the invention, such as a leaflet retainer, neo-leaflet, or neo-annulus, may interact with the mural valve, or be positioned if replacing a leaflet. In other words, an embodiment of the invention may lie in a plane formed by the annulus of the mitral valve as indicated by the middle arrow 3410. Also, an embodiment of the invention may lie either above or below the plane of the annulus, as indicated by the top 3400 and bottom 3420 arrows, respectively. In addition, Figure 34 could also be used to illustrate potential movements when these components of the invention are configured as a spring bridge that spans the mural annulus and actively moves with the valve leaflet(s). A spring bridge may be configured so that it is biased in the open valve position, and is forced shut by increasing pressure within the ventricle.
Alternatively, the spring bridge may not be biased open or closed, but simply move in response to pressure differentials.
Also, the spring bridge may be biased in the closed position.
Figure 35 shows a perspective view of mesh leaflet with buttressing 3500. The embodiment is comprised of a framework 3510 and leaflet retainer 3520. The interior region of the valve orifice 3530 of this embodiment is left open to facilitate the flow of blood between the heart's chambers. The leaflet retainer 3520 prevents native leaflets from being blown into the atrium upon ventricular contraction. The framework 3510 transmits mural pressures to the leaflet retainer, encouraging the leaflet retainer to remain positioned over the native leaflets.
Figure 36 shows a side view of a corona configuration 3600 of the invention.
This embodiment may be used as a framework, to which a leaflet retainer or other valve enhancing device could be attached or coupled to.
Figure 37 shows a perspective view of a corona configuration 3700 of the invention in situ within a patient's left atrium.
Figure 38 shows a cutaway view of a heart, having both native leaflets, 3810 and 3820, intact.
Figure 39 shows a cutaway view of a heart with one embodiment of the invention 3900.
Figure 40 shows a cutaway view of a heart with one intact mural valve leaflet 4010, and one mural valve leaflet excised, or missing. The chords 4020 of the removed leaflet are shown disconnected.
Figure 41 shows a cutaway view of a heart with one embodiment of the invention 4100.
In addition, the shown embodiment has one neo-leaflet 4110. This neo-leaflet 4110 may be rigid, semi-rigid, or flexible.
Figure 42 shows a cutaway view of a heart with both mural valve leaflets removed. The chords 4210 are shown disconnected.
Figure 43 shows a cutaway view of a heart with one embodiment of the invention having two neo-leaflets.
These devices may be delivered to the heart via open heart surgery, through the chest, or through a remote blood vessel. Examples of delivery through a remote blood vessel include the use of guidewires and catheters. They can be advanced into the right atrium through the superior or inferior vena cava (transluminally, via a peripheral venous insertion site, such as the femoral or jugular vein), or into the left ventricle through the aorta. The left atrium can be accessed from the right atrium through the septum. Alternatively, the left atrium can be accessed from the left ventricle through the mitral valve using a transluminal procedure gaining access via a peripheral arterial insertion site, such as the femoral artery. Echo techniques are used to determine whether a patient is experiencing regurgitation, and various imaging techniques can be used to position the device.
The devices shown may be anchored within the left atrium using barbs, staples, adhesives, magnets, etc. In addition, the devices may be coated with various materials to either promote (Dacron) or inhibit (heparin) tissue growth around the devices, to prevent thrombosis, or coated with other desired materials to encourage other desirable characteristics. Anchoring can also be done on the opposite (ventricular) side of the valve.
While the present invention has been described herein with respect to the exemplary embodiments and the best mode for practicing the invention it will become apparent to one of ordinary skill in the art that many modifications, improvements and sub combinations of the various embodiments, adaptations and variations can be made to the invention without departing from the spirit and scope thereof.
Figures 11 and 12 show a perspective view of a dual spring bridge neo-leaflet having an anterior bridge spanned by an anterior material 1110, and a posterior bridge spanned by a posterior material 1120.
Figure 13 shows a perspective view of a damaged native anterior leaflet 1310 that is not connected to the chordae tendineae.
Figure 14 shows a perspective view of a device 1400 having a half sewing ring 1420 with a membrane 1410 that serves as a neo-annulus or a neo-leaflet.
Figure 15 shows a perspective view of a device 1500 having a full sewing ring 1530 with a membrane 1510 that serves as a neo-annulus or a neo-leaflet.
Figure 16 shows a perspective view of a leaflet retainer 1600 that is positioned within the atrium on top of both native mural valve leaflets.
" Figure 17 shows a perspective view of a leaflet retainer 1700 that is positioned within the atrium on top of both native mural valve leaflets.
Figure 18 shows a perspective view of a leaflet retainer 1800~that is positioned within the atrium on top of both native mitral valve leaflets.
Figure 19 shows a perspective view of a leaflet retainer 1900 that is positioned on top of both native mitral valve leaflets.
Figure 20 shows a side view of the embodiment shown in Figure 19.
Figure 21 shows a perspective view of the embodiment shown in Figure 19.
Figure 22 through 26 show the sequence of steps for a catheter-based percutaneous deployment of an embodiment of the invention.
Figure 27 shows a perspective view of an embodiment of the invention 2700 having a framework that partially fills the atrium.
Figure 28 shows a perspective view of an embodiment of the invention 2800 having dual neo-leaflets, 2830 and 2840.
Figure 29 shows a perspective view of an embodiment of the invention 2900 having a leaflet retainer 2910 positioned against a native leaflet as well as a framework structure 2920 that meanders about the atrium without interfering with the pulmonary veins.
Figure 30 shows a perspective view of another embodiment of the invention 3000 consisting of a continuous wire or tube that forms a leaflet retainer and framework.
Figure 31 shows a perspective view of a tulip shaped wire form configuration 3100 of the invention.
Figure 32 shows cutaway view of a tulip shaped wire form configuration 3200 of the invention.
Figure 33 shows a cutaway view of a tulip with a twist wire form configuration 3300 of the invention.
Figure 34 shows a cutaway view of the left atrium and left ventricle. The arrows on the left side of the figure indicate by way of example three different ways in which an embodiment of the invention, such as a leaflet retainer, neo-leaflet, or neo-annulus, may interact with the mitral valve, or be positioned if replacing a leaflet.
Figure 35 shows a perspective view of mesh leaflet with buttressing 3500.
Figure 36 shows a side view of a corona configuration 3600 of the invention.
Figure 37 shows a perspective view of a corona configuration 3700 of the invention in situ within a patient's left atrium.
Figure 38 shows a cutaway view of a heart, having both native leaflets, 3810 and 3820, intact.
Figure 39 shows a cutaway view of a heart with one embodiment of the invention 3900.
Figure 40 shows a cutaway view of a heart with one intact mitral valve leaflet 4010, and one mural valve leaflet excised, or missing.
Figure 41 shows a cutaway view of a heart with one embodiment of the invention 4100.
In addition, the shown embodiment has one neo-leaflet 4110.
Figure 42 shows a cutaway view of a heart with both mural valve leaflets removed.
Figure 43 shows a cutaway view of a heart with one embodiment of the invention having two neo-leaflets.
DETAILED DESCRIPTION
Figure 1 shows a posterior oblique cutaway view of a patient's heart 100. Two of the four heart chambers are shown, the left atrium 170, and the left ventricle 140 (not shown are the right atrium and right ventricle). The left atrium 170 fills with blood from the pulmonary veins.
The blood then passes through the mitral valve (also known as the bicuspid valve, and more generally known as an atrioventricular valve) during ventricular diastole and into the left ventricle 140. During ventricular systole, the blood is then ejected out of the left ventricle 140 through the aortic valve 150 and into the aorta 160. At this time, the mitral valve should be shut so that blood is not regurgitated back into the left atrium. The mitral valve consists of two leaflets, an anterior leaflet 110, and a posterior leaflet 115, attached to chordae tendineae 120 (hereafter, chords), which in turn are connected to papillary muscles 130 within the left atrium 140. Typically, the mitral valve has a D-shaped anterior leaflet 110 oriented toward the aortic valve, with a crescent shaped posterior leaflet 115. The leaflets intersect with the atrium 170 at the mitral annulus 190.
Figure 2 shows a cutaway view of a patient's heart 200 with a prolapsed mural valve that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction. The anterior 220 and posterior 225 leaflets are shown being blown into the left atrium with arrows indicating the direction of regurgitant flow. Among other causes, regurgitation can result from stretched chords 210 that are too long to prevent the leaflets from being blown into the atrium. As a result, the leaflets do not form a tight seal and blood is regurgitated into the atrium.
Figure 3 shows a cutaway view of a patient's heart 300 with a flailing mitral valve 320 that does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction as indicated by arrows. Among other causes, regurgitation can result from torn chords 310.
Figure 4 shows a perspective view of a spring bridge neo-leaflet used to supplement or replace a native leaflet. The device 400 is shown to be formed of a base 420 that is positioned around the mitral annulus, and then closes in over the anterior leaflet to form a bridge 430 over the anterior leaflet. The bridge 430 may be a rigid, semi-rigid, or flexible.
The bridge may act like a spring, and thus respond dynamically to pressure differentials within the heart. The bridge 430 may have a spanning material 410 that spans the bridge 430. The spanning material 410 may be attached to the device 400 with one or more attachment means 440 (for example, it may be sewn, glued, or welded to the device 400, or it may be attached to itself when wrapped around the device 400). The spanning material 410 may be made from a synthetic material (for example, thin Nitinol, Dacron fabric, Polytetrafluoroethylene or PTFE, Silicone, or Polyurethane) or a biological material (for example, human or animal pericardium). The device 400 may be delivered percutaneously, through the chest (thoracoscopy), or using open heart surgical techniques. If delivered percutaneously, the device may be made from a super-elastic material (for example, Nitinol) enabling it to be folded and collapsed such that it can be delivered in a catheter, and will subsequently self expand when released from the catheter. The device may be secured to the mural annulus with sutures or other attachment means (i.e. barbs, hooks, staples, etc).
Figure S shows a perspective view of an embodiment of the invention comprised of a bridge 540, spanning material 530, attachment means SSO, and a base 520. In addition, the device is shown to have a framework S 10. Preferably the framework S 10 does not interfere with atrial contractions, instead contracting with the atrium. As such, the device 500 may have non-uniform flexibility to improve its function within the heart. The framework is shown here rising from the base 520 with two substantially parallel arched wires that connect to form a semicircular hoop above the base 520. The framework 510 helps to accurately position the device within the atrium, and also helps to secure the device within the atrium. The neo-leaflet comprised of the bridge 540 and spanning material 530 is shown in the closed valve position.
Figure 6 shows a perspective view of the embodiment of Figure 5 in the open valve position.
Figure 7 shows a perspective view of the embodiments shown in Figures 5 and 6 positioned within the left atrium of the heart.
Figures 8 and 9 show a perspective view of the embodiments of Figures S and 6 positioned within the left atrium of the heart. Figure 8 shows the embodiment in a closed valve position, and Figure 9 shows the embodiment in an open valve position. The sizing of the base 810 can vary depending upon the patient's needs.
Figure 10 shows a perspective view of an embodiment of the invention having a framework 1010 that avoids the pulmonary veins (not shown).
Figures 11 and 12 show a perspective view of a dual spring bridge neo-leaflet have an anterior bridge spanned by an anterior material 1110, and a posterior bridge spanned by a posterior material 1120. The framework 1130 shown here illustrates an alternative design. This embodiment also illustrates a base having clips 1140 that protrude below an imaginary plane formed by the annulus of the valve. Figure 11 shows the dual neo-leaflets in a closed valve position, and Figure 12 shows the dual neo-leaflets in an open valve position.
Figure 13 shows a perspective view of a damaged native anterior leaflet 1310 that is not connected to the chordae tendineae.
Figure 14 shows a perspective view of a device 1400 having a half sewing ring 1420 with a membrane 1410 that serves as a neo-annulus or a neo-leaflet. When serving as a neo-annulus, the membrane 1410 is a relatively immobile structure covering one of the native valve leaflets, particularly a damaged, missing or nonfunctional leaflet. The neo-annulus serves to extend the native annulus and coapts with the remaining functional native leaflet to create a functioning mitral valve. When serving as a neo-leaflet, the membrane 1410 is a mobile structure that moves in response to blood flow, coapting with one of the native leaflets to create a functioning mural valve. The neo-leaflet replaces the function of a damaged, missing or nonfunctional native leaflet. The device 1400 is attached to the mural valve annulus via the half sewing ring 1420.
This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 15 shows a perspective view of a device 1500 having a full sewing ring 1530 with a membrane 1510 that serves as a neo-annulus or a neo-leaflet. The device 1500 has an opening 1520 though the sewing ring 1530 opposite the membrane 1510 for blood flow.
Alternatively, this embodiment could have two neo-leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 16 shows a perspective view of a leaflet retainer 1600 that is positioned within the atrium on top of both native mural valve leaflets. This embodiment is comprised of an outer ring 1610 and an inner ring 1630 connected by radial struts 1620. The interior region of the valve orifice remains unobstructed to blood flow with this embodiment. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 17 shows a perspective view of a leaflet retainer 1700 that is positioned within the atrium on top of both native mural valve leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 18 shows a perspective view of a leaflet retainer 1800 that is positioned within the atrium on top of both native mitral valve leaflets. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 19 shows a perspective view of a leaflet retainer 1900 that is positioned on top of both native mural valve leaflets. Alternatively, the leaflet retainers may be designed to retain only one leaflet, or a portion of a leaflet, depending on patient needs. The outer sections of this embodiment have anchors 1910 that distribute stresses along the atrial wall, helping to prevent erosion of the atrial walls. This embodiment could be surgically attached to the valve annulus and/or combined with a framework for anchoring the device within the patient's atrium using catheter based intraluminal techniques.
Figure 20 shows a side view of the embodiment shown in Figure 19.
Figure 21 shows a perspective view of the embodiment shown in Figure 19.
Figure 22 through 26 show the sequence of steps for a catheter-based percutaneous deployment of an embodiment of the invention. This deployment technique applies to other embodiments as well. Initially, a guidewire is introduced into the vasculature via a peripheral venous access site, such as the femoral or jugular vein, or alternatively by means of surgical access through the right atrium. Figure 22 shows the introduction of a guidewire 2210 through the septum 2220 between the right and left atria. The guidewire is shown being introduced into the right atrium via the inferior vena cava 2230. Figure 23 shows a catheter 2320 being advanced over the guidewire 2310. Figure 24 shows an embodiment of the invention 2400 being released from the catheter after the guidewire has been removed.
Alternatively, a guidewire could be used to place the device. Figure 25 shows an embodiment of the invention having an additional feature, a looped eyelet 2500 that is being placed within a pulmonary vein to help position the device within the atrial chamber. The looped eyelet 2500 could be advanced over a guidewire. Figure 26 shows an embodiment of the invention 2600 being positioned within the left atrium. The device 2600 can be positioned or repositioned within the atrium using a catheter deployed grasping instrument 2610.
Figure 27 shows a perspective view of an embodiment of the invention 2700 having a framework that partially fills the atrium.
Figure 28 shows a perspective view of an embodiment of the invention 2800 having dual neo-leaflets, 2830 and 2840. The device is comprised of a framework 2810 an annular base 2820, and the neo-leaflets, 2830 and 2840. The neo-leaflets supplement or replace native leaflets, and thus function as a one-way valve to allow blood to flow from the atrium to the ventricle, and to prevent blood from flowing from the ventricle to the atrium.
This is accomplished because the neo-leaflets structure is similar to native leaflet structure.
Figure 29 shows a perspective view of an embodiment of the invention 2900 having a leaflet retainer 2910 positioned against a native leaflet as well as a framework structure 2920 that meanders about the atrium without interfering with the pulmonary veins. The leaflet retainer 2910 prevents the leaflet from prolapsing into the atrium due to the pressure differential during ventricular contractions, thus improving closure of the mitral valve and reducing regurgitation.
Figure 30 shows a perspective view of another embodiment of the invention 3000 consisting of a continuous wire or tube that forms a leaflet retainer and framework. The geometry of the framework is such that it spirals upward within the atrium.
The device 3000 is secured in place because the framework expands within the atrium, and experiences mural pressures. The leaflet retainer is secured in place over 'a native leaflet by its coupling to the framework, and the leaflet retainer functions to prevent the native leaflet from experiencing prolapse. In addition, a coating that promotes tissue growth may aid in the fixation process of the framework within the atrium. However, the leaflet retainer section of the device 3000 may benefit from a coating that inhibits tissue growth, thus allowing the native leaflet to allow blood to flow into the ventricle.
Figure 31 shows a perspective view of a tulip shaped wire form configuration 3100 of the invention.
Figure 32 shows cutaway view of a tulip shaped wire form configuration 3200 of the invention. The illustration shows the device 3200 making contact with native leaflets, 3220 and 1 S 3210, to prevent prolapse. The device 3200 is comprised of a leaflet retainer section that functions to prevent the native leaflets, 3210 and 3220, from being blown into the atrium when the ventricle contracts. The leaflet retaining section is positioned directly over the native leaflets.
In this embodiment, the leaflet retaining aspect of the device 3200 is shown to be integrally formed with the framework section of the device. However, in other embodiments, the leaflet retainer and framework may be separate structures which can be deployed separately for individual use or in combination.
Figure 33 shows a cutaway view of a tulip with a twist wire form configuration 3300 of the invention. The twist aspect enables the device to be shortened through twisting to decrease the longitudinal spring constant. The device 3300 is comprised of a leaflet retainer section that functions to prevent the native leaflets from being blown into the atrium when the ventricle contracts. The leaflet retaining section is positioned directly over the native leaflets. In this embodiment, the leaflet retaining aspect of the device 3300 is shown to be integrally formed with the framework section of the device. However, in other embodiments, the leaflet retainer and framework may be separate structures which can be deployed separately for individual use or in combination.
Figure 34 shows a cutaway view of the left atrium and left ventricle. The arrows on the left side of the figure indicate by way of example three different ways in which an embodiment of the invention, such as a leaflet retainer, neo-leaflet, or neo-annulus, may interact with the mural valve, or be positioned if replacing a leaflet. In other words, an embodiment of the invention may lie in a plane formed by the annulus of the mitral valve as indicated by the middle arrow 3410. Also, an embodiment of the invention may lie either above or below the plane of the annulus, as indicated by the top 3400 and bottom 3420 arrows, respectively. In addition, Figure 34 could also be used to illustrate potential movements when these components of the invention are configured as a spring bridge that spans the mural annulus and actively moves with the valve leaflet(s). A spring bridge may be configured so that it is biased in the open valve position, and is forced shut by increasing pressure within the ventricle.
Alternatively, the spring bridge may not be biased open or closed, but simply move in response to pressure differentials.
Also, the spring bridge may be biased in the closed position.
Figure 35 shows a perspective view of mesh leaflet with buttressing 3500. The embodiment is comprised of a framework 3510 and leaflet retainer 3520. The interior region of the valve orifice 3530 of this embodiment is left open to facilitate the flow of blood between the heart's chambers. The leaflet retainer 3520 prevents native leaflets from being blown into the atrium upon ventricular contraction. The framework 3510 transmits mural pressures to the leaflet retainer, encouraging the leaflet retainer to remain positioned over the native leaflets.
Figure 36 shows a side view of a corona configuration 3600 of the invention.
This embodiment may be used as a framework, to which a leaflet retainer or other valve enhancing device could be attached or coupled to.
Figure 37 shows a perspective view of a corona configuration 3700 of the invention in situ within a patient's left atrium.
Figure 38 shows a cutaway view of a heart, having both native leaflets, 3810 and 3820, intact.
Figure 39 shows a cutaway view of a heart with one embodiment of the invention 3900.
Figure 40 shows a cutaway view of a heart with one intact mural valve leaflet 4010, and one mural valve leaflet excised, or missing. The chords 4020 of the removed leaflet are shown disconnected.
Figure 41 shows a cutaway view of a heart with one embodiment of the invention 4100.
In addition, the shown embodiment has one neo-leaflet 4110. This neo-leaflet 4110 may be rigid, semi-rigid, or flexible.
Figure 42 shows a cutaway view of a heart with both mural valve leaflets removed. The chords 4210 are shown disconnected.
Figure 43 shows a cutaway view of a heart with one embodiment of the invention having two neo-leaflets.
These devices may be delivered to the heart via open heart surgery, through the chest, or through a remote blood vessel. Examples of delivery through a remote blood vessel include the use of guidewires and catheters. They can be advanced into the right atrium through the superior or inferior vena cava (transluminally, via a peripheral venous insertion site, such as the femoral or jugular vein), or into the left ventricle through the aorta. The left atrium can be accessed from the right atrium through the septum. Alternatively, the left atrium can be accessed from the left ventricle through the mitral valve using a transluminal procedure gaining access via a peripheral arterial insertion site, such as the femoral artery. Echo techniques are used to determine whether a patient is experiencing regurgitation, and various imaging techniques can be used to position the device.
The devices shown may be anchored within the left atrium using barbs, staples, adhesives, magnets, etc. In addition, the devices may be coated with various materials to either promote (Dacron) or inhibit (heparin) tissue growth around the devices, to prevent thrombosis, or coated with other desired materials to encourage other desirable characteristics. Anchoring can also be done on the opposite (ventricular) side of the valve.
While the present invention has been described herein with respect to the exemplary embodiments and the best mode for practicing the invention it will become apparent to one of ordinary skill in the art that many modifications, improvements and sub combinations of the various embodiments, adaptations and variations can be made to the invention without departing from the spirit and scope thereof.
Claims (49)
1. A medical device comprising:
a base member having a shape such that it tracks the circumference of a native heart valve annulus;
and a bridge member extending from the base member over the heart valve orifice, and supported by the base member.
a base member having a shape such that it tracks the circumference of a native heart valve annulus;
and a bridge member extending from the base member over the heart valve orifice, and supported by the base member.
2. The medical device of claim 1, further comprising a spanning material, the spanning material suspended from the bridge member, and adjacent portions of the base member, wherein the spanning material is coupled to the bridge member and adjacent portions of the base member by an attachment means.
3. The medical device of claim 1, wherein the bridge member is manufactured from a super-elastic material.
4. The medical device of claim 1, wherein the base member is sized to change the shape of the native valve annulus when attached to the native valve annulus.
5. The medical device of claim 1, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium.
6. The medical device of claim 1, wherein the attachment means is selected from a group consisting of sewing, gluing, welding, and wrapping the spanning material around itself.
7. The medical device of claim 1, further comprising a framework coupled to the base member and rising from the base member and into the surrounding heart chamber, the reactive forces of the heart on the framework transmitted through the framework and into the annulus retainer.
8. The medical device of claim 7, wherein the framework is shaped to avoid the pulmonary veins.
9. A medical device comprising:
a base member shaped such that it tracks the circumference of a native heart valve annulus, a set of bridge members extending from the base member over the heart valve orifice, and supported by the base member, and a spanning material suspended from each bridge member, and adjacent portions of the base member, wherein the spanning material is coupled to the bridge member and adjacent portions of the base member by an attachment means.
a base member shaped such that it tracks the circumference of a native heart valve annulus, a set of bridge members extending from the base member over the heart valve orifice, and supported by the base member, and a spanning material suspended from each bridge member, and adjacent portions of the base member, wherein the spanning material is coupled to the bridge member and adjacent portions of the base member by an attachment means.
10. The medical device of claim 9, wherein the bridge members are manufactured from a super-elastic material.
11. The medical device of claim 9, wherein the base member is sized to change the shape of the native valve annulus when attached to the native valve annulus.
12. The medical device of claim 9, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium.
13. The medical device of claim 9, wherein the attachment means is selected from a group consisting of sewing, gluing, welding, and wrapping the spanning material around itself.
14. The medical device of claim 9, further comprising a framework coupled to the base member and rising from the base member and into the surrounding heart chamber, the reactive forces of the heart on the framework transmitted through the framework and into the annulus retainer.
15. The medical device of claim 14, wherein the framework is shaped to avoid the pulmonary veins.
16. The medical device of claim 9, further including clips, the clips protrude from the base member and press into the ventricular side of the annulus.
17. A medical device comprising:
a semicircular annular ring, and a spanning material, wherein the spanning material is coupled to the semicircular annular ring.
a semicircular annular ring, and a spanning material, wherein the spanning material is coupled to the semicircular annular ring.
18. The medical device of claim 17, wherein the semicircular annular ring is manufactured from a super-elastic material.
19. The medical device of claim 17, wherein the semicircular annular ring is sized to change the shape of the native valve annulus when attached to the native valve annulus.
20. The medical device of claim,17, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium.
21. A medical device comprising:
a circular annular ring, and a spanning material, wherein the spanning material is coupled to the circular annular ring such that the spanning material spans a portion of the circular annular ring to function as a coaptation surface for an functioning native leaflet.
a circular annular ring, and a spanning material, wherein the spanning material is coupled to the circular annular ring such that the spanning material spans a portion of the circular annular ring to function as a coaptation surface for an functioning native leaflet.
22. The medical device of claim 21, wherein the circular annular ring is manufactured from a super-elastic material.
23. The medical device of claim 21, wherein the circular annular ring is sized to change the shape of the native valve annulus when attached to the native valve annulus.
24. The medical device of claim 21, wherein the spanning material is from a group consisting of Nitinol, Dacron fabric, Polytetrafluoroethylene, Silicone, Polyurethane, human pericardium, and animal pericardium.
25. A medical device comprising:
an outer hoop, an inner hoop, and struts that radiate between the inner and outer hoops, wherein the struts are coupled to the outer and inner hoops.
an outer hoop, an inner hoop, and struts that radiate between the inner and outer hoops, wherein the struts are coupled to the outer and inner hoops.
26. The medical device of claim 25, wherein the medical device is manufactured from a super-elastic material.
27. The medical device of claim 25, wherein the medical device is sized to change the shape of the native valve annulus when attached to the native valve annulus.
28. A medical device, comprising:
a wire shaped to encircle the annulus of a heart valve, and radiate along the plane of the annulus both toward and away from the center of the valve orifice in a rhythmic pattern that enables the wire to contact both the valve leaflets and the adjacent heart walls.
a wire shaped to encircle the annulus of a heart valve, and radiate along the plane of the annulus both toward and away from the center of the valve orifice in a rhythmic pattern that enables the wire to contact both the valve leaflets and the adjacent heart walls.
29. The medical device of claim 28, wherein the wire is manufactured from a super-elastic material.
30. The medical device of claim 28, wherein the wire may be deployed from an intravascular catheter device.
31. A medical device, comprising:
a wire shaped to encircle the annulus of a heart valve, and radiate along the plane of the annulus both toward and away from the center of the valve orifice in a rhythmic pattern that enables the wire to contact both the valve leaflets and the adjacent heart walls, the wire contacting the heart walls forming a anchoring member that provides a holding force to the retainer by embedding into adjacent tissue without damaging it.
a wire shaped to encircle the annulus of a heart valve, and radiate along the plane of the annulus both toward and away from the center of the valve orifice in a rhythmic pattern that enables the wire to contact both the valve leaflets and the adjacent heart walls, the wire contacting the heart walls forming a anchoring member that provides a holding force to the retainer by embedding into adjacent tissue without damaging it.
32. The medical device of claim 31, wherein the wire is manufactured from a super-elastic material.
33. A medical device, comprising:
a heart chamber framework having two hoops positioned in approximately parallel planes and connected by vertical struts that are coupled to each hoop.
a heart chamber framework having two hoops positioned in approximately parallel planes and connected by vertical struts that are coupled to each hoop.
34. The medical device of claim 33, wherein the medical device is manufactured from a super-elastic material.
35. A medical device comprising:
a heart chamber framework having a first hoop and a second hoop, the hoops positioned in parallel planes and connected by vertical struts that are coupled to each hoop, and a neo-leaflet coupled to the first hoop, positioned to supplement or replace a native leaflet.
a heart chamber framework having a first hoop and a second hoop, the hoops positioned in parallel planes and connected by vertical struts that are coupled to each hoop, and a neo-leaflet coupled to the first hoop, positioned to supplement or replace a native leaflet.
36. The medical device of claim 35, wherein the framework is manufactured from a super-elastic material.
37. The medical device of claim 35, further comprising a second neo-leaflet coupled to the interior surface of the first hoop, positioned to supplement or replace a native leaflet.
38. A medical device comprising:
a leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over a leaflet and restrict the leaflet's movements upstream of blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
a leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over a leaflet and restrict the leaflet's movements upstream of blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
39. The medical device of claim 38, wherein the medical device is manufactured from a super-elastic material.
40. The medical device of claim 38, wherein the device may be deployed from an intravascular catheter device.
41. A medical device comprising:
a tulip-shaped wire form, wherein the tulip-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
a tulip-shaped wire form, wherein the tulip-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
42. The medical device of claim 41, wherein the wire form is manufactured from a super-elastic material.
43. A medical device comprising:
a twisted tulip-shaped wire form, wherein the twisted tulip-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of normal blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
a twisted tulip-shaped wire form, wherein the twisted tulip-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of normal blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
44. The medical device of claim 43, wherein the wire form is manufactured from a super-elastic material.
45. A medical device comprising:
a mesh-shaped wire form, wherein the mesh-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of normal blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
a mesh-shaped wire form, wherein the mesh-shaped wire form has a framework and leaflet retainer, the leaflet retainer formed of a wire that is shaped to extend over one or more leaflets and restrict the leaflets movements upstream of normal blood flow, and a framework, the framework formed of a wire that is shaped to extend into the upstream heart chamber, and to contact the upstream chamber and transmit force from the chamber to the framework and then to the leaflet retainer, wherein the leaflet retainer and framework are comprised of a continuous wire.
46. The medical device of claim 45, wherein the medical device is manufactured from a super-elastic material.
47. A medical device, comprising:
a corona-shaped wire form, wherein the corona-shaped wire form is formed of a single wire that radiates between the valve base and the chamber apex and contacts the adjacent chamber walls.
a corona-shaped wire form, wherein the corona-shaped wire form is formed of a single wire that radiates between the valve base and the chamber apex and contacts the adjacent chamber walls.
48. The medical device of claim 47, wherein the medical device is manufactured from a super-elastic material.
49. A method for installing medical devices:
introducing a guidewire into a patient's blood vessel;
advancing the guidewire into the heart;
advancing a catheter over the guidewire, the catheter pre-loaded with a medical device comprising:
a base member, the base member having a shape that tracks the circumference of a native heart valve annulus; and a bridge member, the bridge member extending from the base member over the heart valve orifice, and supported by the base member;
advancing the catheter within the vessel so that the medical device reaches its desired position within the heart;
releasing the medical device into the desired location within the heart;
positioning the medical device within the desired location of the heart;
and withdrawing the catheter from the patient.
introducing a guidewire into a patient's blood vessel;
advancing the guidewire into the heart;
advancing a catheter over the guidewire, the catheter pre-loaded with a medical device comprising:
a base member, the base member having a shape that tracks the circumference of a native heart valve annulus; and a bridge member, the bridge member extending from the base member over the heart valve orifice, and supported by the base member;
advancing the catheter within the vessel so that the medical device reaches its desired position within the heart;
releasing the medical device into the desired location within the heart;
positioning the medical device within the desired location of the heart;
and withdrawing the catheter from the patient.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32659001P | 2001-10-01 | 2001-10-01 | |
| US60/326,590 | 2001-10-01 | ||
| PCT/US2002/031376 WO2003028558A2 (en) | 2001-10-01 | 2002-10-01 | Methods and devices for heart valve treatments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2455444A1 true CA2455444A1 (en) | 2003-04-10 |
Family
ID=23272862
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002455444A Abandoned CA2455444A1 (en) | 2001-10-01 | 2002-10-01 | Methods and devices for heart valve treatments |
| CA002462254A Abandoned CA2462254A1 (en) | 2001-10-01 | 2002-10-01 | Devices for treating atrial fibrilation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002462254A Abandoned CA2462254A1 (en) | 2001-10-01 | 2002-10-01 | Devices for treating atrial fibrilation |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7291168B2 (en) |
| EP (1) | EP1434542A2 (en) |
| JP (1) | JP4458845B2 (en) |
| CN (2) | CN100333704C (en) |
| AU (1) | AU2002362442B2 (en) |
| CA (2) | CA2455444A1 (en) |
| HK (1) | HK1073423A1 (en) |
| WO (1) | WO2003028558A2 (en) |
Families Citing this family (319)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
| US6269819B1 (en) * | 1997-06-27 | 2001-08-07 | The Trustees Of Columbia University In The City Of New York | Method and apparatus for circulatory valve repair |
| FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
| US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
| WO2006116558A2 (en) * | 1999-04-09 | 2006-11-02 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
| US7666204B2 (en) | 1999-04-09 | 2010-02-23 | Evalve, Inc. | Multi-catheter steerable guiding system and methods of use |
| WO2000060995A2 (en) | 1999-04-09 | 2000-10-19 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
| US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
| US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
| US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
| US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
| US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
| EP1113497A3 (en) * | 1999-12-29 | 2006-01-25 | Texas Instruments Incorporated | Semiconductor package with conductor impedance selected during assembly |
| ITPC20000013A1 (en) * | 2000-04-13 | 2000-07-13 | Paolo Ferrazzi | INTROVENTRICULAR DEVICE AND RELATED METHOD FOR THE TREATMENT AND CORRECTION OF MYOCARDIOPATHIES. |
| US8784482B2 (en) * | 2000-09-20 | 2014-07-22 | Mvrx, Inc. | Method of reshaping a heart valve annulus using an intravascular device |
| US7691144B2 (en) | 2003-10-01 | 2010-04-06 | Mvrx, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
| US7527646B2 (en) * | 2000-09-20 | 2009-05-05 | Ample Medical, Inc. | Devices, systems, and methods for retaining a native heart valve leaflet |
| US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
| US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
| US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
| AU2003277115A1 (en) * | 2002-10-01 | 2004-04-23 | Ample Medical, Inc. | Device and method for repairing a native heart valve leaflet |
| JP2006501033A (en) * | 2002-10-01 | 2006-01-12 | アンプル メディカル， インコーポレイテッド | Device, system and method for reshaping a heart valve annulus |
| US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
| US6997950B2 (en) * | 2003-01-16 | 2006-02-14 | Chawla Surendra K | Valve repair device |
| US20050107871A1 (en) * | 2003-03-30 | 2005-05-19 | Fidel Realyvasquez | Apparatus and methods for valve repair |
| US7658759B2 (en) * | 2003-04-24 | 2010-02-09 | Cook Incorporated | Intralumenally implantable frames |
| US10646229B2 (en) | 2003-05-19 | 2020-05-12 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
| WO2004103223A1 (en) * | 2003-05-20 | 2004-12-02 | The Cleveland Clinic Foundation | Apparatus and methods for repair of a cardiac valve |
| US8052751B2 (en) * | 2003-07-02 | 2011-11-08 | Flexcor, Inc. | Annuloplasty rings for repairing cardiac valves |
| US20050004665A1 (en) * | 2003-07-02 | 2005-01-06 | Lishan Aklog | Annuloplasty rings and methods for repairing cardiac valves |
| WO2005007036A1 (en) * | 2003-07-18 | 2005-01-27 | Brivant Research & Development Limited | A device for correcting inversion of the leaflets of a leaflet valve in the heart |
| JP4447011B2 (en) * | 2003-07-21 | 2010-04-07 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | Percutaneous heart valve |
| US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
| US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
| EP1734903B2 (en) | 2004-03-11 | 2022-01-19 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
| US7942927B2 (en) | 2004-03-15 | 2011-05-17 | Baker Medical Research Institute | Treating valve failure |
| EP3143944B1 (en) | 2004-05-14 | 2018-08-01 | Evalve, Inc. | Locking mechanisms for fixation devices |
| WO2006002492A1 (en) * | 2004-07-06 | 2006-01-12 | Baker Medical Research Institute | Treating valvular insufficiency |
| US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
| JP2008513060A (en) | 2004-09-14 | 2008-05-01 | エドワーズ ライフサイエンシーズ アーゲー | Device and method for treatment of heart valve regurgitation |
| CA2581852C (en) | 2004-09-27 | 2012-11-13 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
| US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
| WO2006041877A2 (en) * | 2004-10-05 | 2006-04-20 | Ample Medical, Inc. | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
| SE0403046D0 (en) * | 2004-12-15 | 2004-12-15 | Medtentia Ab | A device and method for improving the function of a heart valve |
| DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
| US20060173490A1 (en) | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
| US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
| US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
| WO2011034628A1 (en) | 2005-02-07 | 2011-03-24 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
| US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
| WO2006086434A1 (en) | 2005-02-07 | 2006-08-17 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
| US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
| JP4740619B2 (en) * | 2005-02-17 | 2011-08-03 | サンゴ エッセ．ア．エッセ． ディ カッターニ リータ エ チ． | External support for venous valves to restore capacity by traction of their commissural walls |
| WO2006089236A1 (en) * | 2005-02-18 | 2006-08-24 | The Cleveland Clinic Foundation | Apparatus and methods for replacing a cardiac valve |
| US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
| EP1853199B1 (en) * | 2005-02-28 | 2014-10-29 | Medtentia International Ltd Oy | Devices for improving the function of a heart valve |
| WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
| US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
| US20060259135A1 (en) * | 2005-04-20 | 2006-11-16 | The Cleveland Clinic Foundation | Apparatus and method for replacing a cardiac valve |
| SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
| CA2606101A1 (en) * | 2005-04-25 | 2006-11-02 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
| US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
| US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
| WO2007025028A1 (en) * | 2005-08-25 | 2007-03-01 | The Cleveland Clinic Foundation | Percutaneous atrioventricular valve and method of use |
| CN102113923B (en) | 2005-09-07 | 2014-05-07 | 梅德坦提亚国际有限公司 | A device for improving the function of a heart valve |
| US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
| US7797607B2 (en) * | 2005-12-27 | 2010-09-14 | Lg Electronics, Inc. | DTV transmitter and method of coding main and enhanced data in DTV transmitter |
| US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
| US7749249B2 (en) | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
| US7635386B1 (en) * | 2006-03-07 | 2009-12-22 | University Of Maryland, Baltimore | Methods and devices for performing cardiac valve repair |
| US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
| US20070282429A1 (en) * | 2006-06-01 | 2007-12-06 | Hauser David L | Prosthetic insert for improving heart valve function |
| US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
| EP2068765B1 (en) | 2006-07-31 | 2018-05-09 | Syntheon TAVR, LLC | Sealable endovascular implants |
| US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
| US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
| US20080033541A1 (en) * | 2006-08-02 | 2008-02-07 | Daniel Gelbart | Artificial mitral valve |
| US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
| FR2906454B1 (en) * | 2006-09-28 | 2009-04-10 | Perouse Soc Par Actions Simpli | IMPLANT INTENDED TO BE PLACED IN A BLOOD CIRCULATION CONDUIT. |
| US8694077B2 (en) | 2006-10-06 | 2014-04-08 | The Cleveland Clinic Foundation | Apparatus and method for targeting a body tissue |
| WO2008070262A2 (en) | 2006-10-06 | 2008-06-12 | The Cleveland Clinic Foundation | Apparatus and method for targeting a body tissue |
| SE530568C2 (en) * | 2006-11-13 | 2008-07-08 | Medtentia Ab | Medical device for improving function of heart valve, has flange unit connected to loop-shaped support and provided to be arranged against annulus when loop shaped support abut heart valve |
| WO2010004546A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
| US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
| US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| JP2010511469A (en) * | 2006-12-05 | 2010-04-15 | バルテック カーディオ，リミティド | Segmented ring placement |
| US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
| US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
| US8070802B2 (en) * | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
| US20080208328A1 (en) * | 2007-02-23 | 2008-08-28 | Endovalve, Inc. | Systems and Methods For Placement of Valve Prosthesis System |
| US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
| US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
| US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
| US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
| US9814611B2 (en) | 2007-07-31 | 2017-11-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
| US8216303B2 (en) * | 2007-11-19 | 2012-07-10 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
| WO2010070649A1 (en) | 2008-12-21 | 2010-06-24 | Mor Research Applications Ltd. | Elongated body for deployment in a coronary sinus |
| US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
| EP2695587A1 (en) | 2008-01-25 | 2014-02-12 | JenaValve Technology Inc. | Medical apparatus for the therapeutic treatment of an insufficient cardiac valve |
| US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
| BR112012021347A2 (en) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
| US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
| US20100121435A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
| US20100131057A1 (en) | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
| US20100121437A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
| US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
| US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
| US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
| US8262725B2 (en) * | 2008-04-16 | 2012-09-11 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
| DK3967274T3 (en) | 2008-04-23 | 2022-10-03 | Medtronic Inc | HEART VALVE DEVICES WITH STENT |
| WO2009132187A1 (en) * | 2008-04-23 | 2009-10-29 | Medtronic, Inc. | Stented heart valve devices |
| US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
| US20090287304A1 (en) | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
| US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
| US8337390B2 (en) * | 2008-07-30 | 2012-12-25 | Cube S.R.L. | Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heart |
| CA2776475A1 (en) * | 2008-10-10 | 2010-04-15 | Peter Forsell | An improved artificial valve |
| EP2358297B1 (en) | 2008-11-21 | 2019-09-11 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis |
| US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
| US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
| US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
| US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
| US8940044B2 (en) | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
| US8926696B2 (en) | 2008-12-22 | 2015-01-06 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices and adjustment mechanisms therefor |
| US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
| US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
| EP2633821B1 (en) | 2009-09-15 | 2016-04-06 | Evalve, Inc. | Device for cardiac valve repair |
| US20120179184A1 (en) | 2009-09-15 | 2012-07-12 | Boris Orlov | Heart valve remodeling |
| US20110077733A1 (en) * | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
| US20110082538A1 (en) | 2009-10-01 | 2011-04-07 | Jonathan Dahlgren | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
| US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
| US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
| US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
| WO2011067770A1 (en) | 2009-12-02 | 2011-06-09 | Valtech Cardio, Ltd. | Delivery tool for implantation of spool assembly coupled to a helical anchor |
| US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
| US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
| US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
| US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
| US9522062B2 (en) * | 2010-02-24 | 2016-12-20 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
| ES2761298T3 (en) | 2010-03-05 | 2020-05-19 | Edwards Lifesciences Corp | Retention mechanisms for prosthetic valves |
| WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
| EP2558007A4 (en) | 2010-04-13 | 2017-11-29 | Sentreheart, Inc. | Methods and devices for accessing and delivering devices to a heart |
| BR112012029896A2 (en) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | prosthetic heart valve for stent graft and stent graft |
| US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
| EP2590595B1 (en) | 2010-07-09 | 2015-08-26 | Highlife SAS | Transcatheter atrio-ventricular valve prosthesis |
| US8657872B2 (en) | 2010-07-19 | 2014-02-25 | Jacques Seguin | Cardiac valve repair system and methods of use |
| US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
| US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
| WO2012012761A2 (en) | 2010-07-23 | 2012-01-26 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
| US10105224B2 (en) | 2010-09-01 | 2018-10-23 | Mvalve Technologies Ltd. | Cardiac valve support structure |
| CN103237523A (en) * | 2010-09-01 | 2013-08-07 | M阀门技术有限公司 | Cardiac valve support structure |
| US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
| US9289295B2 (en) | 2010-11-18 | 2016-03-22 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
| US9198756B2 (en) | 2010-11-18 | 2015-12-01 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
| EP2661239B1 (en) | 2011-01-04 | 2019-04-10 | The Cleveland Clinic Foundation | Apparatus for treating a regurgitant heart valve |
| EP2478868A1 (en) | 2011-01-25 | 2012-07-25 | The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth | Implant device |
| WO2012103173A2 (en) * | 2011-01-25 | 2012-08-02 | Emory University | Devices and methods for surgical and percutaneous repair of heart valve lesions |
| US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
| US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
| US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
| US10500038B1 (en) | 2011-05-20 | 2019-12-10 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve |
| US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
| US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
| EP3395298A1 (en) | 2011-06-27 | 2018-10-31 | University of Maryland, Baltimore | Transapical mitral valve repair device |
| US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
| US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
| EP2739214B1 (en) | 2011-08-05 | 2018-10-10 | Cardiovalve Ltd | Percutaneous mitral valve replacement and sealing |
| US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
| WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
| US8945177B2 (en) | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
| US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
| US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
| EP3656434B1 (en) | 2011-11-08 | 2021-10-20 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
| EP2591754B1 (en) * | 2011-11-10 | 2015-02-25 | Medtentia International Ltd Oy | A device and a method for improving the function of a heart valve |
| US9445893B2 (en) | 2011-11-21 | 2016-09-20 | Mor Research Applications Ltd. | Device for placement in the tricuspid annulus |
| US10143452B2 (en) * | 2011-12-05 | 2018-12-04 | Pi-Cardia Ltd. | Fracturing calcifications in heart valves |
| CN104220027B (en) | 2012-01-31 | 2017-11-07 | 米特拉尔维尔福科技有限责任公司 | Bicuspid valve parking device, system and method |
| CA2869365A1 (en) * | 2012-04-05 | 2013-10-10 | Mvalve Technologies Ltd. | Cardiac valve support structure |
| JP6219377B2 (en) | 2012-05-20 | 2017-10-25 | テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド | Artificial mitral valve |
| DE102012010798A1 (en) * | 2012-06-01 | 2013-12-05 | Universität Duisburg-Essen | Implantable device for improving or eliminating heart valve insufficiency |
| US9216018B2 (en) | 2012-09-29 | 2015-12-22 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
| EP2908743B1 (en) | 2012-10-22 | 2018-08-22 | The Cleveland Clinic Foundation | Apparatus for targeting a body tissue |
| EP2911594B1 (en) | 2012-10-23 | 2018-12-05 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
| US10376266B2 (en) | 2012-10-23 | 2019-08-13 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
| WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
| CN105007832B (en) | 2013-01-09 | 2018-01-23 | 4科技有限公司 | Organize ancora equipment |
| ES2934670T3 (en) | 2013-01-24 | 2023-02-23 | Cardiovalve Ltd | Ventricularly Anchored Prosthetic Valves |
| US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
| WO2014136056A1 (en) * | 2013-03-04 | 2014-09-12 | Medical Research, Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Cardiac valve commissure brace |
| WO2014141239A1 (en) | 2013-03-14 | 2014-09-18 | 4Tech Inc. | Stent with tether interface |
| US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
| WO2014144247A1 (en) | 2013-03-15 | 2014-09-18 | Arash Kheradvar | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
| EP2968847B1 (en) | 2013-03-15 | 2023-03-08 | Edwards Lifesciences Corporation | Translation catheter systems |
| CR20160094A (en) | 2013-08-14 | 2018-03-05 | Mitral Valve Tech Sarl | EQUIPMENT AND METHODS TO IMPLEMENT A REPLACEMENT CARDIAC VALVE |
| JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
| US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
| US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
| US10646333B2 (en) | 2013-10-24 | 2020-05-12 | Medtronic, Inc. | Two-piece valve prosthesis with anchor stent and valve component |
| US10166098B2 (en) | 2013-10-25 | 2019-01-01 | Middle Peak Medical, Inc. | Systems and methods for transcatheter treatment of valve regurgitation |
| US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
| US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
| US10258408B2 (en) | 2013-10-31 | 2019-04-16 | Sentreheart, Inc. | Devices and methods for left atrial appendage closure |
| US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
| US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
| US9681864B1 (en) | 2014-01-03 | 2017-06-20 | Harpoon Medical, Inc. | Method and apparatus for transapical procedures on a mitral valve |
| EP3107499A4 (en) | 2014-02-20 | 2018-03-14 | Mitral Valve Technologies Sàrl | Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device |
| EP4248914A2 (en) | 2014-02-21 | 2023-09-27 | Mitral Valve Technologies Sàrl | Prosthetic mitral valve and anchoring device |
| US9572666B2 (en) * | 2014-03-17 | 2017-02-21 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
| US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
| EP3157469B1 (en) | 2014-06-18 | 2021-12-15 | Polares Medical Inc. | Mitral valve implants for the treatment of valvular regurgitation |
| EP3157607B1 (en) | 2014-06-19 | 2019-08-07 | 4Tech Inc. | Cardiac tissue cinching |
| CA2958065C (en) | 2014-06-24 | 2023-10-31 | Middle Peak Medical, Inc. | Systems and methods for anchoring an implant |
| EP3928743A1 (en) * | 2014-06-26 | 2021-12-29 | Boston Scientific Scimed Inc. | Medical devices and methods to prevent bile reflux after bariatric procedures |
| EP3174502B1 (en) | 2014-07-30 | 2022-04-06 | Cardiovalve Ltd | Apparatus for implantation of an articulatable prosthetic valve |
| US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
| EP3922213A1 (en) | 2014-10-14 | 2021-12-15 | Valtech Cardio, Ltd. | Leaflet-restraining techniques |
| JP6717820B2 (en) | 2014-12-02 | 2020-07-08 | ４テック インコーポレイテッド | Eccentric tissue anchor |
| US9517131B2 (en) | 2014-12-12 | 2016-12-13 | Than Nguyen | Cardiac valve repair device |
| US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
| US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
| CN110141399B (en) | 2015-02-05 | 2021-07-27 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with axially sliding frame |
| US10231834B2 (en) | 2015-02-09 | 2019-03-19 | Edwards Lifesciences Corporation | Low profile transseptal catheter and implant system for minimally invasive valve procedure |
| US10039637B2 (en) | 2015-02-11 | 2018-08-07 | Edwards Lifesciences Corporation | Heart valve docking devices and implanting methods |
| US20160235525A1 (en) | 2015-02-12 | 2016-08-18 | Medtronic, Inc. | Integrated valve assembly and method of delivering and deploying an integrated valve assembly |
| US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
| WO2016154168A1 (en) * | 2015-03-23 | 2016-09-29 | St. Jude Medical, Cardiology Division, Inc. | Heart valve repair |
| US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
| CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
| CN107530168B (en) | 2015-05-01 | 2020-06-09 | 耶拿阀门科技股份有限公司 | Device and method with reduced pacemaker ratio in heart valve replacement |
| US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
| US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
| US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
| US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
| WO2017035002A1 (en) * | 2015-08-21 | 2017-03-02 | Twelve Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
| US10034747B2 (en) | 2015-08-27 | 2018-07-31 | Medtronic Vascular, Inc. | Prosthetic valve system having a docking component and a prosthetic valve component |
| US20170056215A1 (en) | 2015-09-01 | 2017-03-02 | Medtronic, Inc. | Stent assemblies including passages to provide blood flow to coronary arteries and methods of delivering and deploying such stent assemblies |
| WO2017059426A1 (en) | 2015-10-02 | 2017-04-06 | Harpoon Medical, Inc. | Distal anchor apparatus and methods for mitral valve repair |
| US10022223B2 (en) | 2015-10-06 | 2018-07-17 | W. L. Gore & Associates, Inc. | Leaflet support devices and methods of making and using the same |
| US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
| US9872765B2 (en) | 2015-10-12 | 2018-01-23 | Venus Medtech (Hangzhou) Inc | Mitral valve assembly |
| US9592121B1 (en) | 2015-11-06 | 2017-03-14 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
| CN108472135B (en) | 2015-12-10 | 2021-02-02 | 姆维亚克斯股份有限公司 | Devices, systems, and methods for reshaping a heart valve annulus |
| US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
| EP3397207A4 (en) | 2015-12-30 | 2019-09-11 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
| US10363130B2 (en) | 2016-02-05 | 2019-07-30 | Edwards Lifesciences Corporation | Devices and systems for docking a heart valve |
| US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
| EP3231393B1 (en) | 2016-04-13 | 2023-06-21 | Christian Vallbracht | Minimally invasive implantable mitral and tricuspid valve |
| US10624743B2 (en) | 2016-04-22 | 2020-04-21 | Edwards Lifesciences Corporation | Beating-heart mitral valve chordae replacement |
| WO2017191549A1 (en) * | 2016-05-05 | 2017-11-09 | LAINCHBURY, John George | Device for the treatment of mitral valve prolapse |
| EP3243485A1 (en) | 2016-05-11 | 2017-11-15 | Berlin Heart GmbH | Holding device for a sewing ring |
| EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
| US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
| WO2017217932A1 (en) * | 2016-06-13 | 2017-12-21 | Singapore Health Services Pte. Ltd. | Device for cardiac valve repair and method of implanting the same |
| US10588745B2 (en) | 2016-06-20 | 2020-03-17 | Medtronic Vascular, Inc. | Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis |
| US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
| GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
| US10828150B2 (en) * | 2016-07-08 | 2020-11-10 | Edwards Lifesciences Corporation | Docking station for heart valve prosthesis |
| CA3031187A1 (en) | 2016-08-10 | 2018-02-15 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
| USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
| US10383725B2 (en) * | 2016-08-11 | 2019-08-20 | 4C Medical Technologies, Inc. | Heart chamber prosthetic valve implant with base, mesh and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function |
| US10722359B2 (en) | 2016-08-26 | 2020-07-28 | Edwards Lifesciences Corporation | Heart valve docking devices and systems |
| CR20190069A (en) | 2016-08-26 | 2019-05-14 | Edwards Lifesciences Corp | Heart valve docking coils and systems |
| US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
| US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
| US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
| US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
| US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
| US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
| CR20190308A (en) | 2016-12-20 | 2020-01-24 | Edwards Lifesciences Corp | Systems and mechanisms for deploying a docking device for a replacement heart valve |
| WO2018119304A1 (en) | 2016-12-22 | 2018-06-28 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
| US10653523B2 (en) | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
| US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
| US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
| US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
| US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
| CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
| USD867595S1 (en) | 2017-02-01 | 2019-11-19 | Edwards Lifesciences Corporation | Stent |
| US20180256329A1 (en) * | 2017-03-07 | 2018-09-13 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
| US10653524B2 (en) | 2017-03-13 | 2020-05-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
| US10478303B2 (en) | 2017-03-13 | 2019-11-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
| EP3595587A4 (en) | 2017-03-13 | 2020-11-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
| EP3592288B1 (en) | 2017-03-27 | 2021-09-01 | TruLeaf Medical Ltd. | Docking elements |
| US10765515B2 (en) | 2017-04-06 | 2020-09-08 | University Of Maryland, Baltimore | Distal anchor apparatus and methods for mitral valve repair |
| US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
| US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
| US11065119B2 (en) | 2017-05-12 | 2021-07-20 | Evalve, Inc. | Long arm valve repair clip |
| CA3065223A1 (en) | 2017-06-19 | 2018-12-27 | Harpoon Medical, Inc. | Method and apparatus for cardiac procedures |
| CR20190571A (en) | 2017-06-30 | 2020-04-19 | Edwards Lifesciences Corp | Docking stations transcatheter valves |
| BR112019027404A2 (en) | 2017-06-30 | 2020-07-07 | Edwards Lifesciences Corporation | locking and releasing mechanisms for implantable transcatheter devices |
| US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
| US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
| US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
| US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
| US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
| USD890333S1 (en) | 2017-08-21 | 2020-07-14 | Edwards Lifesciences Corporation | Heart valve docking coil |
| CA3076928A1 (en) | 2017-10-24 | 2019-05-02 | University Of Maryland, Baltimore | Method and apparatus for cardiac procedures |
| US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
| US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
| GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
| GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
| CN111655199B (en) | 2018-01-22 | 2023-09-26 | 爱德华兹生命科学公司 | Heart-shaped maintenance anchor |
| WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
| EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
| US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
| US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
| US11517435B2 (en) | 2018-05-04 | 2022-12-06 | Edwards Lifesciences Corporation | Ring-based prosthetic cardiac valve |
| AU2019301967A1 (en) | 2018-07-12 | 2021-01-21 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty systems and locking tools therefor |
| US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
| EP3620133A1 (en) * | 2018-09-07 | 2020-03-11 | AVVie GmbH | Implant for improving coaptation of an artrioventricular valve |
| US11395738B2 (en) | 2018-09-25 | 2022-07-26 | Truleaf Medical Ltd. | Docking elements |
| US11944536B2 (en) * | 2019-08-13 | 2024-04-02 | The Chinese University Of Hong Kong | Transcatheter self-expandable tricuspid valve replacement system |
| WO2021084407A1 (en) | 2019-10-29 | 2021-05-06 | Valtech Cardio, Ltd. | Annuloplasty and tissue anchor technologies |
| US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
| US11464634B2 (en) | 2020-12-16 | 2022-10-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors |
| US11759321B2 (en) | 2021-06-25 | 2023-09-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
| CN114474029B (en) * | 2022-02-16 | 2023-09-01 | 之江实验室 | High-frequency driven thermal response artificial muscle |
| CN117426808B (en) * | 2023-12-21 | 2024-03-08 | 北京华脉泰科医疗器械股份有限公司 | Skirt edge structure, self-adaptive skirt edge bracket, plugging device and skirt edge manufacturing method |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056854A (en) * | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
| US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
| JPH05184611A (en) | 1991-03-19 | 1993-07-27 | Kenji Kusuhara | Valvular annulation retaining member and its attaching method |
| US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
| FR2688692A1 (en) * | 1992-03-20 | 1993-09-24 | Seguin Jacques | Prosthetic ring for reconstruction surgery of the aortic valve |
| CN2135346Y (en) * | 1992-09-12 | 1993-06-09 | 中国人民解放军第四军医大学第一附属医院 | Plasticity bicuspid valve shaping ring |
| US5263977A (en) * | 1992-10-26 | 1993-11-23 | Angeion Corporation | Electrode spacing device |
| FR2708847B1 (en) * | 1993-08-13 | 1995-11-03 | Couetil Jean Paul | Implantable heart valve. |
| FR2726657B1 (en) * | 1994-11-07 | 1996-12-06 | Metrix | DEVICE FOR MEASURING AND / OR ANALYZING DISTURBANCES IN THE SECTOR |
| US5545241B1 (en) * | 1995-01-17 | 1999-09-28 | Donaldson Co Inc | Air cleaner |
| US5716417A (en) * | 1995-06-07 | 1998-02-10 | St. Jude Medical, Inc. | Integral supporting structure for bioprosthetic heart valve |
| WO1997016135A1 (en) * | 1995-11-01 | 1997-05-09 | St. Jude Medical, Inc. | Bioresorbable annuloplasty prosthesis |
| US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
| US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
| DE19625202A1 (en) * | 1996-06-24 | 1998-01-02 | Adiam Medizintechnik Gmbh & Co | Prosthetic mitral heart valve |
| DE19624951A1 (en) * | 1996-06-24 | 1998-01-02 | Adiam Medizintechnik Gmbh & Co | Prosthetic heart valve |
| US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
| US6183411B1 (en) * | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
| US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
| US5961440A (en) | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
| US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
| US5776189A (en) * | 1997-03-05 | 1998-07-07 | Khalid; Naqeeb | Cardiac valvular support prosthesis |
| US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
| US6250308B1 (en) * | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
| US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
| US6102932A (en) * | 1998-12-15 | 2000-08-15 | Micrus Corporation | Intravascular device push wire delivery system |
| ATE379998T1 (en) * | 1999-01-26 | 2007-12-15 | Edwards Lifesciences Corp | FLEXIBLE HEART VALVE |
| WO2000060995A2 (en) * | 1999-04-09 | 2000-10-19 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
| US6312464B1 (en) * | 1999-04-28 | 2001-11-06 | NAVIA JOSé L. | Method of implanting a stentless cardiac valve prosthesis |
| US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
| SE514718C2 (en) | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
| US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
| US6210222B1 (en) * | 1999-12-13 | 2001-04-03 | Eagle Comtronics, Inc. | Coaxial cable connector |
| US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
| US6537198B1 (en) * | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
| US6419695B1 (en) * | 2000-05-22 | 2002-07-16 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heart valve |
| ATE381291T1 (en) * | 2000-06-23 | 2008-01-15 | Viacor Inc | AUTOMATIC ANNUAL FOLDING FOR MITRAL VALVE REPAIR |
| JP3854045B2 (en) * | 2000-07-25 | 2006-12-06 | オリンパス株式会社 | Endoscope |
| US7510572B2 (en) * | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
| US6616684B1 (en) | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
| US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
| US6913608B2 (en) * | 2000-10-23 | 2005-07-05 | Viacor, Inc. | Automated annular plication for mitral valve repair |
| US7070618B2 (en) * | 2000-10-25 | 2006-07-04 | Viacor, Inc. | Mitral shield |
| WO2002062408A2 (en) | 2001-02-05 | 2002-08-15 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
| US6955689B2 (en) * | 2001-03-15 | 2005-10-18 | Medtronic, Inc. | Annuloplasty band and method |
| US7037334B1 (en) * | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
| DE60225303T2 (en) * | 2001-08-31 | 2009-02-26 | Mitral Interventions, Redwood City | DEVICE FOR A HEART LAPSE REPAIR |
| US20030120340A1 (en) | 2001-12-26 | 2003-06-26 | Jan Liska | Mitral and tricuspid valve repair |
| US6764510B2 (en) * | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
| US7112219B2 (en) * | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US6945978B1 (en) * | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
| US7004176B2 (en) * | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
| SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
-
2002
- 2002-10-01 WO PCT/US2002/031376 patent/WO2003028558A2/en active Application Filing
- 2002-10-01 EP EP02800430A patent/EP1434542A2/en not_active Withdrawn
- 2002-10-01 JP JP2003531900A patent/JP4458845B2/en not_active Expired - Fee Related
- 2002-10-01 CA CA002455444A patent/CA2455444A1/en not_active Abandoned
- 2002-10-01 AU AU2002362442A patent/AU2002362442B2/en not_active Ceased
- 2002-10-01 CN CNB028194756A patent/CN100333704C/en not_active Expired - Fee Related
- 2002-10-01 CA CA002462254A patent/CA2462254A1/en not_active Abandoned
- 2002-10-01 CN CNA2007101271547A patent/CN101108144A/en active Pending
-
2003
- 2003-10-28 US US10/695,433 patent/US7291168B2/en not_active Expired - Lifetime
-
2005
- 2005-08-25 HK HK05107461A patent/HK1073423A1/en not_active IP Right Cessation
-
2007
- 2007-10-25 US US11/977,493 patent/US20080140190A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20080140190A1 (en) | 2008-06-12 |
| CN100333704C (en) | 2007-08-29 |
| CN101108144A (en) | 2008-01-23 |
| EP1434542A2 (en) | 2004-07-07 |
| US7291168B2 (en) | 2007-11-06 |
| AU2002362442B2 (en) | 2008-08-07 |
| HK1073423A1 (en) | 2005-10-07 |
| CN1610529A (en) | 2005-04-27 |
| JP2005504577A (en) | 2005-02-17 |
| US20040138745A1 (en) | 2004-07-15 |
| JP4458845B2 (en) | 2010-04-28 |
| WO2003028558A8 (en) | 2003-10-30 |
| WO2003028558A2 (en) | 2003-04-10 |
| CA2462254A1 (en) | 2003-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002362442B2 (en) | Methods and devices for heart valve treatments | |
| AU2002362442A1 (en) | Methods and devices for heart valve treatments | |
| US11717401B2 (en) | Prosthetic heart valve assembly | |
| JP7149052B2 (en) | A stent for positioning and securing a valvular prosthesis at an implantation site in a patient's heart | |
| JP6514174B2 (en) | Endoprosthesis | |
| US8016882B2 (en) | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet | |
| US7803187B2 (en) | Device and method for reshaping mitral valve annulus | |
| JP2020531189A (en) | Diameter catheter device for treating mitral regurgitation | |
| US20060025857A1 (en) | Implantable prosthetic valve | |
| US20060287661A1 (en) | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ | |
| EP3184082A1 (en) | Stent for a surgical valve | |
| US20210298896A1 (en) | Prosthetic hemi heart valve | |
| EP4132427A1 (en) | Prosthetic hem i heart valve | |
| CN116157096A (en) | Prosthetic valve device for treating mitral insufficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |